Investing.com -- Immuneering Corp (NASDAQ:IMRX) stock surged 21.7% Monday after the clinical-stage oncology company announced ...

Discover how President Trump's Most Favored Nation policy aims to slash U.S. prescription drug prices by up to 1500% and its potential political impact.

Immuneering Corporation (IMRX) on Monday announced a clinical supply agreement with Eli Lilly and Company (LLY) for the ...

Shares of Immuneering rose after the company entered into a clinical supply agreement for Eli Lilly's olomorasib drug to support testing of Immuneering's proposed lung-cancer treatment. The stock was ...

Immuneering (IMRX) partners with Eli Lilly to test atebimetinib + olomorasib in a phase 2 trial targeting KRAS G12c-mutant ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

VANCOUVER, British Columbia and KIBBUTZ YIFAT, Israel, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Beyond Oil Ltd. (CSE:BOIL) (OTCQB:BEOLF) ('Beyond Oil” or the 'Company”), a food-tech innovation company ...